SBIR/STTR Research Award

Targeting Neurons Involved in Chronic Pain Transmission

Award identifier 6d3eb92e6336736822acadbcefc1eea542980698a5f4faa0ba5b1e81bb9165ccAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$133,547

Program and phase

SBIR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Advanced Targeting Systems
Proposal award date
Not reported
Contract end date
Not reported
UEI
Z8PDT5YVMP24
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (Adapted from applicant's abstract): Chronic pain is an enormous problem in the United States: it is estimated that 30 to 100 million people suffer from it. Often, current treatments are ineffective and the population of sufferers is often described as "under-served." According to recent data, chronic pain is transmitted through the Substance P receptor-expressing neurons of the dorsal horn of the spinal cord. Elimination of these neurons terminates transmission of the chronic pain signal in several rat models. However, this method relied on the death of spinal cord neurons. An alternative method that would maintain the integrity of the neuronal system would be to only disrupt the activities of these neurons. This could be achieved by internalizing molecules into Substance P receptor-expressing neurons that interfere with the ability to transmit the chronic pain signal. It is proposed in this Phase I application to demonstrate that an expression system, useful for expressing molecules that can cause this disruption, can be internalized into Substance P receptor-expressing neurons and can express a marker protein, green fluorescent protein. The success of this application could result in the resolution of serious problems that interfere with the treatment of chronic pain. PROPOSED COMMERCIAL APPLICATION: This proposal will result in the development of an expression system for use in internally manipulating cells to disrupt or alter their function. Such a system would have many applications in scientific research, not only in chronic pain, but in any area where scientists seek to alter cell processes. Additionally, an expression system that can diminish rather than destroy a cell's function would have great possibility in the treatment of disease.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

15 SBIR/STTR records share this UEI (1995–2017). Reported award amounts total $2,304,907. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.